Search Contract Opportunities

BARDA Nonclinical Development Biological Network   9

ID: 75A50122R00008 • Type: Solicitation

Description

The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies such as chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases.

Together with our industry partners, BARDA promotes the advanced development of medical countermeasures (MCM) to protect Americans and respond to 21st century health security threats.

The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) MCM Review (2010) recommended that PHEMCE partners provide not only financial help to medical countermeasure developers but also technical and regulatory assistance. BARDA's Strategic Plan (2011) set a goal to provide assistance to developers through core assistance programs in critical areas including nonclinical and clinical services to obtain safety and efficacy data supporting MCM development.

To meet the demands for MCM development and support an ever-increasing need for nonclinical services including those required to address 21st Century Threats and BARDA's innovation activities, this solicitation seeks to establish a Nonclinical Services Network of laboratories providing expertise, capacity, and program management across three capability areas:

Capability Area 1: Animal Model Development and MCM Testing (Biological Agents)

Capability Area 2: Analytical Method Development, Qualification, Validation, and Testing

Capability Area 3: Safety and Toxicity Testing

BARDA anticipates awarding multiple IDIQ contracts that provide a guaranteed minimum award to the organizations or consortiums that meet the overall qualifications needed to fulfill the technical requirements of this solicitation for each capability area. Sample Task Orders are provided in the RFP solely to evaluate Offerors' responses and capabilities. Responses for Task Order Requests (RTORs) for specific tasks will be issued after award of the Parent Contract. This IDIQ will be administered and used to support BARDA initiatives as necessary to help accomplish its mission.

Overview

Response Deadline
May 20, 2022, 2:00 p.m. EDT Past Due
Posted
April 6, 2022, 3:15 p.m. EDT (updated: May 12, 2022, 5:00 p.m. EDT)
Set Aside
None
Place of Performance
United States
Source
SAM

Current SBA Size Standard
1000 Employees
Pricing
Fixed Price; Cost Plus Fixed Fee;
Evaluation Criteria
Best Value
On 4/6/22 HHS Office of the Assistant Secretary for Preparedness and Response issued Solicitation 75A50122R00008 for BARDA Nonclinical Development Biological Network due 5/20/22. The opportunity was issued full & open with NAICS 541714 and PSC AN13.
Primary Contact
Name
Andrew Sargeant   Profile
Phone
(202) 868-0048

Secondary Contact

Name
Jeffrey Brown   Profile
Phone
(202) 730-8662

Documents

Posted documents for Solicitation 75A50122R00008

Question & Answer

Opportunity Lifecycle

Procurement notices related to Solicitation 75A50122R00008

Award Notifications

Agency published notification of awards for Solicitation 75A50122R00008

IDV Awards

Indefinite delivery vehicles awarded through Solicitation 75A50122R00008

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation 75A50122R00008

Similar Active Opportunities

Open contract opportunities similar to Solicitation 75A50122R00008

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE > BARDA - ASPR / DAAPPO / BARDA DCMA
FPDS Organization Code
7505-00100
Source Organization Code
100188027
Last Updated
June 4, 2022
Last Updated By
andrew.sargeant@hhs.gov
Archive Date
June 4, 2022